ea0064007 | Low dose continuous IV etomidate for severe Cushing’s syndrome in the non-critical care setting: a clinical study | BES2019
Constantinescu SM
, Lefebvre A
, Furnica RM
, Maiter D
Introduction: Severe Cushings syndrome (CS) is defined by extremely high serum cortisol levels (usually >1000 nM), along with severe and deadly complications, including sepsis, heart failure, acute psychosis, vascular thrombosis, digestive haemorrhage and bowel perforation. Rapid control of such hypercortisolism is mandatory and has been shown to decrease operative mortality and complications. Oral treatments such as ketoconazole and metyrapone are often inadequate i...